Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Background: Moderate and high efficacy disease modifying therapies (DMTs) have a profound effect on disease activity. The current treatment guidelines only recommend high efficacy DMTs for patients with highly active MS. The objective was to examine the impact of initial treatment choice in achievin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248666/
https://ncbi.nlm.nih.gov/pubmed/34220694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.693017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares